Risk of SARS-CoV-2 infection and COVID-19 prognosis with the use of renin–angiotensin–aldosterone system (RAAS) inhibitors: a systematic review

[1] Zhu N(2020)A novel coronavirus from patients with pneumonia in China N Engl J Med 382 727-733

[2] Zhang D(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 395 492-506

[3] Wang W(2020)Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus infected pneumonia in Wuhan, China JAMA 323 1061-1069

[4] Li X(2020)Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China Allergy 75 1730-1741

[5] Yang B(2020)Clinical course and risk factors for mortality of adult in-patients with COVID-19 in Wuhan, China; a retrospective cohort study Lancet 395 1054-1062

[6] Song J(2015)Intrapulmonay activation of angiotensin-converting enzyme type 2/angiotensin 1-7/G-protein-coupled Mas receptor axis attenuates pulmonary hypertension in Ren-2 transgenic rats exposed to chronic hypoxia Physiol Res 6 25-38

[7] Zhao X(2020)SARS-CoV-2 cell entry depends on ACE2 and TMPRSS 2 and is blocked by clinically proven protease inhibitor Cell. 181 271-280.e8

[8] Huang B(2005)Effects of angiotensin-converting enzyme inhibition and angiotensin 11 receptor blockers on cardiac angiotensin-converting enzyme 2 Circulation 111 2605-2610

[9] Si W(2010)Differential downregulatin of ACE2 by spike proteins of severe acute respiratory syndrome coronavirus and human coronaviruses NL63 J Virol 84 1198-1205

[10] Lu R(2012)A pneumonia outbreak associated with a new coronavirus of probable bat origin Nature 579 270-273

[1] Zhu N(2020)A novel coronavirus from patients with pneumonia in China N Engl J Med 382 727-733

[2] Zhang D(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 395 492-506

[3] Wang W(2020)Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus infected pneumonia in Wuhan, China JAMA 323 1061-1069

[4] Li X(2020)Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China Allergy 75 1730-1741

[5] Yang B(2020)Clinical course and risk factors for mortality of adult in-patients with COVID-19 in Wuhan, China; a retrospective cohort study Lancet 395 1054-1062

[6] Song J(2015)Intrapulmonay activation of angiotensin-converting enzyme type 2/angiotensin 1-7/G-protein-coupled Mas receptor axis attenuates pulmonary hypertension in Ren-2 transgenic rats exposed to chronic hypoxia Physiol Res 6 25-38

[7] Zhao X(2020)SARS-CoV-2 cell entry depends on ACE2 and TMPRSS 2 and is blocked by clinically proven protease inhibitor Cell. 181 271-280.e8

[8] Huang B(2005)Effects of angiotensin-converting enzyme inhibition and angiotensin 11 receptor blockers on cardiac angiotensin-converting enzyme 2 Circulation 111 2605-2610

[9] Si W(2010)Differential downregulatin of ACE2 by spike proteins of severe acute respiratory syndrome coronavirus and human coronaviruses NL63 J Virol 84 1198-1205

[10] Lu R(2012)A pneumonia outbreak associated with a new coronavirus of probable bat origin Nature 579 270-273